Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation - ScienceDirect
The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models | Journal of Neuroinflammation | Full Text
Neuronal Mitochondria Modulation of LPS-Induced Neuroinflammation | Journal of Neuroscience
Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis - Figure f10 | Aging
![PDF] Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/40b2123121854064d06277f761d5ca441fa15fd2/6-Figure2-1.png "PDF] Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons | Semantic Scholar")
PDF] Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons | Semantic Scholar
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
Frontiers | The Gut–Brain Axis and Its Relation to Parkinson's Disease: A Review
Experimental Neurobiology
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
MicroRNA‐3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease - Lv - 2021 - Journal of Neurochemistry - Wiley Online Library
LPS-Induced Neuroinflammation Model - Creative Biolabs
Lipopolysaccharide Animal Models for Parkinson's Disease
Chronic neuroinflammation generated by a single LPS injection (15 × 10⁶... | Download Scientific Diagram
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
Is Porphyromonas gingivalis involved in Parkinson's disease? | SpringerLink
Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation: Cell
Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins | PLOS ONE
Is Porphyromonas gingivalis involved in Parkinson's disease? | SpringerLink
DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice
IJMS | Free Full-Text | Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models
LPS induces chronic neuroinflammation with heterogeneous densities of... | Download Scientific Diagram
Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text
Impact of Aging and Gut Microbiota on Neuroinflammation and Parkinson's Disease | PerkinElmer
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
